Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding

BACKGROUND: Information on the effectiveness of nirmatrelvir/ritonavir against the omicron is limited. The clinical response and viral kinetics to therapy in the real world need to be evaluated. METHODS: Mild to moderate coronavirus disease 2019 (COVID-19) patients with risk factors for severe illne...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunyoung, Park, Sehee, Choi, Jae-Phil, Kim, Min-Kyung, Yang, Eunmi, Ham, Sin Young, Lee, Seungjae, Lee, Bora, Yang, Jeong-Sun, Park, Byoung Kwon, Kim, Da Sol, Lee, So-Young, Lee, Joo-Yeon, Jang, Hee-Chang, Jeon, Jaehyun, Park, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970787/
https://www.ncbi.nlm.nih.gov/pubmed/36852855
http://dx.doi.org/10.3346/jkms.2023.38.e59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970787/
https://www.ncbi.nlm.nih.gov/pubmed/36852855
http://dx.doi.org/10.3346/jkms.2023.38.e59

Ejemplares similares